Listeriosis

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2010, Pages 470-488

  Bortolussi, Robert ^a   Mailman, Timothy L ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866421540     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6400-8.00013-4     Document Type: Chapter

References (315)

1. Nyfeldt A. Étiologie de la mononucléose infectieuse. Compt. Rend. Biol. 1929, 101:590.
2. Murray E.D.G., Webb R.A., Swann M.B.R. A disease of rabbits characterized by a large mononuclear leucocytosis, caused by a hitherto undescribed Bacillus: Bacterium monocytogenes. J. Pathol. Bacteriol. 1926, 29:407.
3. Pirie J.H.H. A new disease of veld rodents. Tiger River disease 1927, 3:163.
4. Pirie J.H.H. Change of name for a genus of bacteria. Nature 1940, 145:264.
5. Bille J., Doyle M.P. Listeria and Erysipelothrix. Manual of Clinical Microbiology 1991, 287-295. American Society of Microbiology, Washington, DC. fifth ed. A. Ballows (Ed.).
6. Seeliger H.R.P. Listeriosis 1961, S Karger, Basel.
7. Peel M., Donachie W., Shaw A. Temperature-dependent expression of flagella of Listeria monocytogenes studied by electron microscopy, SDS-PAGE and western blotting. J. Gen. Microbiol. 1988, 134:2171.
8. van Netten P., et al. Liquid and solid selective differential media for the detection and enumeration of L. monocytogenes and other Listeria species. Int. J. Food. Microbiol. 1989, 8:299.
9. Gray M.L., et al. A new technique for isolating listerellae from the bovine brain. J. Bacteriol. 1948, 55:471.
10. Cepeda J.A., et al. Listeriosis due to infection with a catalase-negative strain of Listeria monocytogenes. J. Clin. Microbiol. 2006, 44:1917-1918.
11. Seeliger H.R.P., Jones D. Genus Listeria. Berge's Manual of Systematic Bacteriology 1986, vol. 2. Williams & Wilkins, Baltimore. P.H.A. Sneeth (Ed.).
12. Seeliger H.R.P., Finger H. Analytical serology of Listeria. Analytical Serology of Microorganisms 1969, 549. John Wiley, New York. J.B.G. Kwapinski (Ed.).
13. Liu D. Identification, subtyping and virulence determination of Listeria monocytogenes, an important foodborne pathogen. J. Med. Microbiol. 2006, 55(Pt 6):645-659.
14. Sword C.P., Pickett M.J. The isolation and characterization of bacteriophages from Listeria monocytogenes. J. Gen. Microbiol. 1961, 25:241.
15. McLauchlin J., Audurier A., Taylor A.G. The evaluation of a phage-typing system for Listeria monocytogenes for use in epidemiological studies. J. Med. Microbiol. 1986, 22:357.
16. Schlech W.F., et al. Epidemic listeriosis-evidence for transmission by food. N. Engl. J. Med. 1983, 308:203.
17. Piffaretti J.C., et al. Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:3818.
18. Graves L.M., et al. Ribosomal DNA fingerprinting of Listeria monocytogenes using a digoxigenin-labeled DNA probe. Eur. J. Epidemiol. 1991, 7:77.
19. Richardson B.P., Adams M. Allozyme Electrophoresis: A Handbook for Animal Systematics and Population Studies 1986, Academic Press, Orlando, FL.
20. Carriere C., et al. DNA polymorphism in strains of Listeria monocytogenes. J. Clin. Microbiol. 1991, 29:1351.
21. Slade P.J., Collins-Thompson D.L. Differentiation of the genus Listeria from other gram-positive species based on low molecular weight (LMW) RNA profiles. J. Appl. Bacteriol. 1991, 70:355.
22. Bille J.R.J., Swaminathan B. Listeria and erysipelothrix. Manual of Clinical Microbiology 2003, 461-471. AMS Press, Washington, DC. eighth ed. P.R. Murray (Ed.).
23. Portnoy D.A., et al. Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 1992, 60:1263.
24. Vazquez-Boland J.A., et al. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 2001, 14:584-640.
25. Ramaswamy V., et al. Listeria-review of epidemiology and pathogenesis. J. Microbiol. Immunol. Infect. 2007, 40:4-13.
26. Gray M.J., Freitag N.E., Boor K.J. How the bacterial pathogen Listeria monocytogenes mediates the switch from environmental Dr. Jekyll to pathogenic Mr. Hyde. Infect. Immun. 2006, 74:2505-2512.
27. Gottesman S., Wickner S., Maurizi M.R. Protein quality control: triage by chaperones and proteases. Genes Dev. 1997, 11:815-823.
28. van Schaik W., Abee T. The role of sigmaB in the stress response of Gram-positive bacteria-targets for food preservation and safety. Curr. Opin. Biotechnol. 2005, 16:218-224.
29. Saklani-Jusforgues H., Fontan E., Goossens P.L. Effect of acid-adaptation on Listeria monocytogenes survival and translocation in a murine intragastric infection model. FEMS Microbiol. Lett. 2000, 193:155-159.
30. Gaillard J.L., et al. Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell 1991, 65:1127.
31. Ireton K., Cossart P. Host-pathogen interactions during entry and actin-based movement of Listeria monocytogenes. Annu. Rev. Genet. 1997, 31:113-138.
32. Sabet C., et al. The Listeria monocytogenes virulence factor InlJ is specifically expressed in vivo and behaves as an adhesin. Infect. Immun. 2008, 76:1368-1378.
33. Lecuit M., et al. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 1999, 18:3956-3963.
34. Hess J., et al. Listeria monocytogenes p60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium. Infect. Immun. 1995, 63:2047-2053.
35. Harty J.T., Pamer E.G. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J. Immunol. 1995, 154:4642-4650.
36. Seveau S., Pizarro-Cerda J., Cossart P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes. Infect. 2007, 9:1167-1175.
37. Portnoy D.A., Jacks P.S., Hinrichs D.J. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 1988, 167:1459.
38. Moors M.A., et al. Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect. Immun. 1999, 67:131-139.
39. Shetron-Rama L.M., et al. Intracellular induction of Listeria monocytogenes actA expression. Infect. Immun. 2002, 70:1087-1096.
40. Kocks C., et al. Polarized distribution of Listeria monocytogenes surface protein ActA at the site of directional actin assembly. J. Cell. Sci. 1993, 105(Pt 3):699-710.
41. Vazquez-Boland J.A., et al. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithinase in cell-to-cell spread. Infect. Immun. 1992, 60:219.
42. Raveneau J., et al. Reduced virulence of a Listeria monocytogenes phospholipase-deficient mutant obtained by transposon insertion into the zinc metalloprotease gene. Infect. Immun. 1992, 60:916.
43. Mengaud J., et al. Pleiotropic control of Listeria monocytogenes virulence factors by a gene that is autoregulated. Mol. Microbiol. 1991, 5:2273.
44. Domann E., et al. Identification and characterization of a novel PrfA-regulated gene in Listeria monocytogenes whose product, IrpA, is highly homologous to internalin proteins, which contain leucine-rich repeats. Infect. Immun. 1997, 65:101-109.
45. Michel E., et al. Characterization of a large motility gene cluster containing the cheR, motAB genes of Listeria monocytogenes and evidence that PrfA downregulates motility genes. FEMS. Microbiol. Lett. 1998, 169:341-347.
46. Liu P.V., Bates J.L. An extracellular haemorrhagic toxin produced by Listeria monocytogenes. Can. J. Microbiol. 1961, 7:107.
47. Leimeister-Wachter M., Domann E., Chakraborty T. The expression of virulence genes in Listeria monocytogenes is thermoregulated. J. Bacteriol. 1992, 174:947-952.
48. Stanley N.F. Studies on Listeria monocytogenes. I. Isolation of a monocytosis-producing agent. Aust. J. Exp. Biol. Med. Sci. 1949, 27:123.
49. Shum D.T., Galsworthy S.B. Stimulation of monocyte production by an endogenous mediator induced by a component from Listeria monocytogenes. Immunology 1982, 46:343.
50. Welshimer H.J. Isolation of Listeria monocytogenes from vegetation. J. Bacteriol. 1968, 95:300.
51. Low J.C., Renton C.P. Septicaemia, encephalitis and abortions in a housed flock of sheep caused by Listeria monocytogenes type 1/2. Vet. Rec. 1985, 114:147.
52. Owen C.R., et al. A case of primary cutaneous listeriosis. N. Engl. J. Med. 1960, 262:1026.
53. McLauchlin J., Low J.C. Primary cutaneous listeriosis in adults: an occupational disease of veterinarians and farmers. Vet. Rec. 1994, 135:615-617.
54. Elischerova K., Stupalova S. Listeriosis in professionally exposed persons. Acta. Microbiol. Acad. Sci. Hung. 1972, 19:379.
55. Bojsen-Moller J. Human listeriosis: Diagnostic, epidemiological and clinical studies. Acta. Pathol. Microbiol. Scand. Suppl. 1972, 229:1.
56. Goulet V., et al. Increasing incidence of listeriosis in France and other European countries. Emerg. Infect. Dis. 2008, 14:734-740.
57. Doorduyn Y., et al. Invasive Listeria monocytogenes infections in the Netherlands, 1995-2003. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:433-442.
58. Gerner-Smidt P., et al. Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality. Clin. Microbiol. Infect. 2005, 11:618-624.
59. Koch J., Stark K. Significant increase of listeriosis in Germany-epidemiological patterns 2001-2005. Euro. Surveill. 2006, 11:85-88.
60. CDC Outbreak of listeriosis-northeastern United States, 2002. MMWR. Morb. Mortal. Wkly Rep. 2002, 51:950-951.
61. Schlech W.F. Foodborne listeriosis. Clin. Infect. Dis. 2000, 31:770-775.
62. Tienungoon S., et al. Growth limits of Listeria monocytogenes as a function of temperature, pH, NaCl, and lactic acid. Appl. Environ. Microbiol. 2000, 66:4979-4987.
63. McLauchlin J., et al. Human listeriosis and pate: a possible association. BMJ 1991, 303:773-775.
64. Lepoutre A., et al. Epidemie de listerioses en France. Epidemiol. Hebdonv. 1992, 25:115.
65. CDC Multistate outbreak of listeriosis-United States, 2000. MMWR Morb. Mortal. Wkly Rep. 2000, 49:1129-1130.
66. Rorvik L.M., et al. Molecular epidemiological survey of Listeria monocytogenes in seafoods and seafood-processing plants. Appl. Environ. Microbiol. 2000, 66:4779-4784.
67. Olsen S.J., et al. Multistate outbreak of Listeria monocytogenes infection linked to delicatessen turkey meat. Clin. Infect. Dis. 2005, 40:962-967.
68. Mead P.S., et al. Nationwide outbreak of listeriosis due to contaminated meat. Epidemiol. Infect. 2006, 134:744-751.
69. Vaillant V., et al. Foodborne infections in France. Foodborne Pathog. Dis. 2005, 2:221-232.
70. Lynch M., et al. Surveillance for foodborne-disease outbreaks-United States, 1998-2002. MMWR Surveill. Summ. 2006, 55:1-42.
71. Farber J.M., Ross W.H., Harwig J. Health risk assessment of Listeria monocytogenes in Canada. Int. J. Food Microbiol. 1996, 1-2:145-156. 30.
72. McLaughlin J., Greenwood M.H., Pini P.M. The occurrence of Listeria monocytogenes in cheese from a manufacturer associated with a case of listeriosis. Int. J. Food Microbiol. 1990, 10:25.
73. Pinner R.W., et al. Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. JAMA 1992, 267:2046.
74. Varma J.K., et al. Listeria monocytogenes infection from foods prepared in a commercial establishment: a case-control study of potential sources of sporadic illness in the United States. Clin. Infect. Dis. 2007, 44:521-528.
75. Voetsch A.C., et al. Reduction in the incidence of invasive listeriosis in foodborne diseases active surveillance network sites, 1996-2003. Clin. Infect. Dis. 2007, 44:513-520.
76. Klontz K.C., et al. Role of the U.S. Food and Drug Administration in the regulatory management of human listeriosis in the United States. J. Food Prot. 2008, 71:1277-1286.
77. Gellin B.G., et al. The epidemiology of listeriosis in the United States-1986. Listeriosis Study Group. Am. J. Epidemiol. 1991, 133:392.
78. Siegman-Igra Y., et al. Listeria monocytogenes infection in Israel and review of cases worldwide. Emerg. Infect. Dis. 2002, 8:305-310.
79. Paul M.L., et al. Listeriosis-a review of eighty-four cases. Med. J. Aust. 1994, 160:489-493.
80. Newton L., et al. Listeriosis surveillance: 1990. CDR (Lond Eng Rev) 1991, 1:R110-R113.
81. Schlech W.F., et al. Does sporadic Listeria gastroenteritis exist? A 2-year population-based survey in Nova Scotia, Canada. Clin. Infect. Dis. 2005, 41:778-784.
82. Mascola L., et al. Fecal carriage of Listeria monocytogenes: observations during a community-wide, common-source outbreak. Clin. Infect. Dis. 1992, 15:557-558.
83. Varughese P.V., Carter A.O. Human listeriosis in Canada-1988. Can. Dis. Wkly Rep. 1989, 15:213.
84. Schmidt-Wolf G., Seeliger H.P., Schretten-Brunner A. Menschilishe listeroisise-erkrankungen in der Bundesrepublik Deutschland 1969-1985. Zentralbl. Bakteriol. Mikrobiol. Hyg. 1985, 265:472.
85. Nolla-Salas J., et al. Perinatal listeriosis: a population-based multicenter study in Barcelona, Spain (1990-1996). Am. J. Perinatol. 1998, 15:461-467.
86. McLaughlin J. Human listeriosis in Britain, 1967-1985, a summary of 722 cases: 1. Listeriosis during pregnancy and the newborn. Epidemiol. Infect. 1990, 104:181.
87. Lamont R.J., Postlethwaite R. Carriage of Listeria monocytogenes and related species in pregnant and non-pregnant women in Aberdeen, Scotland. J. Infect. 1986, 13:187.
88. Louria D.B., et al. Listeriosis complicating malignant disease: a new association. Ann. Intern. Med. 1967, 67:261.
89. Schuchat A., Swaminathan B., Broome C.V. Epidemiology of human listeriosis. Clin. Microbiol. Rev. 1991, 4:169.
90. Lorber B. Listeriosis. Clin. Infect. Dis. 1997, 24:1-9.
91. Miller J.K., Hedberg M. Effects of cortisone on susceptibility of mice to Listeria monocytogenes. Am. J. Clin. Pathol. 1965, 43:248.
92. Hugin A.W., et al. Effect of cyclosporin A on immunity to Listeria monocytogenes. Infect. Immun. 1986, 52:12.
93. Petit J.C., et al. Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect. Immun. 1985, 49:383.
94. Stamm A.M., et al. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev. Infect. Dis. 1982, 4:665.
95. Gellin B.G., Broome C.V. Listeriosis. JAMA 1989, 261:1313.
96. Cabellos C., et al. Community-acquired bacterial meningitis in cirrhotic patients. Clin. Microbiol. Infect. 2008, 14:35-40.
97. Nieman R.E., Lorber B. Listeriosis in adults: a changing pattern. Report of eight cases and review of the literature, 1968-1978. Rev. Infect. Dis. 1980, 2:207.
98. Schlech W.F., Chase D.P., Badley A. A model of foodborne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose. Int. J. Food. Microbiol. 1993, 18:15.
99. Ho J.L., et al. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch. Intern. Med. 1986, 146:520.
100. Florman A.L., Sundararajan V. Listeriosis among nursery mates. Pediatrics 1968, 41:784.
101. Larson S. Listeria monocytogenes causing hospital-acquired enterocolitis and meningitis in newborn infants. BMJ 1978, 2:473.
102. Filice G.A., et al. Listeria monocytogenes infection in neonates: investigation of an epidemic. J. Infect. Dis. 1978, 138:17.
103. Campbell A.N., Sill P.R., Wardle J.K. Listeria meningitis acquired by cross infection in a delivery suite. Lancet 1981, 2:752.
104. Nelson K.E., et al. Transmission of neonatal listeriosis in a delivery room. Am. J. Dis. Child. 1985, 139:903.
105. Simmons M.D., Cockcroft P.M., Okubadejo O.A. Neonatal listeriosis due to cross-infection in an obstetric theatre. J. Infect. 1986, 13:235.
106. Graham J.C., et al. Hospital-acquired listeriosis. J. Hosp. Infect. 2002, 51:136-139.
107. Guevara R.E., et al. Listeria monocytogenes in platelets: a case report. Transfusion 2006, 46:305-309.
108. Schuchat A., et al. Outbreak of neonatal listeriosis associated with mineral oil. Pediatr. Infect. Dis. J. 1991, 10:183.
109. Smith M.A., et al. Dose-response model for Listeria monocytogenes-induced stillbirths in nonhuman primates. Infect. Immun. 2008, 76:726-731.
110. Lecuit M. Understanding how Listeria monocytogenes targets and crosses host barriers. Clin. Microbiol. Infect. 2005, 11:430-436.
111. Mitsuyama M., et al. Three phases of phagocyte contribution to resistance against Listeria monocytogenes. J. Gen. Microbiol. 1978, 106:165.
112. Cossart P., Mengaud J. Listeria monocytogenes: a model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 1989, 6:463.
113. Denis M. Growth of Listeria monocytogenes in murine macrophages and its modulation by cytokines: activation of bactericidal activity by interleukin-4 and interleukin-6. Can. J. Microbiol. 1991, 37:253.
114. Kolb-Maurer A., et al. Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect. Immun. 2000, 68:3680-3688.
115. Gregory S.H., Sagnimeni A.J., Wing E.J. Expression of the inlAB operon by Listeria monocytogenes is not required for entry into hepatic cells in vivo. Infect. Immun. 1996, 64:3983-3986.
116. Marquis H., Doshi V., Portnoy D.A. The broad-range phospholipase C and a metalloprotease mediate listeriolysin O-independent escape of Listeria monocytogenes from a primary vacuole in human epithelial cells. Infect. Immun. 1995, 63:4531-4534.
117. Bouwer H.G., et al. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants. Infect. Immun. 1994, 62:1039-1045.
118. Gedde M.M., et al. Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes. Infect. Immun. 2000, 68:999-1003.
119. Carrero J.A., Vivanco-Cid H., Unanue E.R. Granzymes drive a rapid listeriolysin O-induced T cell apoptosis. J. Immunol. 2008, 181:1365-1374.
120. Dubail I., et al. Functional assembly of two membrane-binding domains in listeriolysin O, the cytolysin of Listeria monocytogenes. Microbiology 2001, 147:2679-2688.
121. Bonnemain C., et al. Differential roles of multiple signal peptidases in the virulence of Listeria monocytogenes. Mol. Microbiol. 2004, 51:1251-1266.
122. Southwick F.S., Purich D.L. Intracellular pathogenesis of listeriosis. N. Engl. J. Med. 1996, 334:770-776.
123. Kocks C., et al. Listeria monocytogenes induced actin assembly requires the actA gene product, a surface protein. Cell 1992, 68:521.
124. de Chastellier C., Berche P. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect. Immun. 1994, 62:543-553.
125. McGregor D.D., Chen-Woan M. The cellular response to Listeria monocytogenes is mediated by a heterogeneous population of immunospecific T cells. Clin. Invest. Med. 1984, 7:243.
126. Porter B.B., Harty J.T. The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display. Infect. Immun. 2006, 74:1528-1536.
127. Shen H., et al. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 1998, 92:535-545.
128. Kaufmann S.H., Ladel C.H. Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. Trends Microbiol. 1994, 2:235-242.
129. Havell E.A., Spitalny G.L., Patel P.J. Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection. J. Exp. Med. 1982, 156:112.
130. H1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
131. Serody J.S., et al. CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes. Immunology 1996, 88:544-550.
132. Harty J.T., Bevan M.J. CD8 T-cell recognition of macrophages and hepatocytes results in immunity to Listeria monocytogenes. Infect. Immun. 1996, 64:3632-3640.
133. Conlan J.W., North R.J. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 1992, 60:5164-5171.
134. Tuma R.A., et al. Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus. J. Clin. Invest. 2002, 110:1493-1501.
135. Chen-Woan M., McGregor D.D., Goldschneider I. Activation of Listeria monocytogenes-induced prekiller T cells by interleukin-2. Clin. Invest. Med. 1984, 7:287.
136. Kaufmann S.H., Hug E., De Libero G. Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells. J. Exp. Med. 1986, 164:363.
137. Guo Y., et al. Listeria monocytogenes activation of human peripheral blood lymphocytes: induction of non-major histocompatibility complex-restricted cytotoxic activity and cytokine production. Infect. Immun. 1992, 60:1813.
138. Conlan W., North R. Neutrophil-mediated lysis of infected hepatocytes: selective lysis of permissive host cells is a strategy for controlling intracellular infection in the liver parenchyma. Am. Soc. Microbiol. News 1993, 59:563-567.
139. Boockvar K.S., et al. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 1994, 62:1089-1100.
140. Beckerman K.P., et al. Release of nitric oxide during the T cell-independent pathway of macrophage activation: its role in resistance to Listeria monocytogenes. J. Immunol. 1993, 150:888-895.
141. Lien E., Ingalls R.R. Toll-like receptors. Crit. Care. Med. 2002, 30:S1-S11.
142. Marr K.A., et al. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun. 2003, 71:5280-5286.
143. Seki E., et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 2002, 169:3863-3883.
144. Edelson B.T., Unanue E.R. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 2002, 169:3869-3875.
145. Brandl K., et al. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 2007, 204:1891-1900.
146. Nakane A., et al. Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect. Immun. 1989, 57:3331.
147. Havell E.A. Production of tumor necrosis factor during murine listeriosis. J. Immunol. 1987, 139:4225.
148. Havell E.A. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 1989, 143:2894.
149. Nakane A., Minagawa T., Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 1988, 56:2563.
150. van Furth R., et al. Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs. J. Infect. Dis. 1994, 170:234-237.
151. Wagner R.D., Czuprynski C.J. Cytokine mRNA expression in livers of mice infected with Listeria monocytogenes. J. Leukoc. Biol. 1993, 53:525-531.
152. Buchmeier N.A., Schreiber R.D. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:7404.
153. Tsukada H., et al. Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect. Immun. 1991, 59:3589.
154. Havell E.A. Augmented induction of interferons during Listeria monocytogenes infection. J. Infect. Dis. 1986, 153:960.
155. Suzue K., et al. In vivo role of IFN-gamma produced by antigen-presenting cells in early host defense against intracellular pathogens. Eur. J. Immunol. 2003, 33:2666-2675.
156. Wang Q., et al. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 2001, 69:2270-2276.
157. Yan S.R., et al. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 2004, 72:1223.
158. Miller M.A., et al. IL-12-assisted immunization generates CD4+ T cell-mediated immunity to Listeria monocytogenes. Cell. Immunol. 2003, 222:1-14.
159. Neighbors M., et al. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon gamma production. J. Exp. Med. 2001, 194:343-354.
160. Chan C.W., et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 2006, 12:207-213.
161. Grau G.E., et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 1989, 320:1586.
162. Bermudez L.E., Young L.S. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 1988, 140:3006.
163. Flesch I.E., Kaufmann S.H. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 1990, 58:2675.
164. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 1996, 334:1717-1725.
165. Sung S.S., et al. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 1988, 168:1539-1551.
166. Cui W., et al. Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable gram-positive and gram-negative bacteria. J. Endotoxin. Res. 2003, 9:225-236.
167. Nishimura H., et al. The role of gamma delta T cells in priming macrophages to produce tumor necrosis factor-alpha. Eur. J. Immunol. 1995, 25:1465-1468.
168. Mira J.P., et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999, 282:561-568.
169. Ferrante A., et al. Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites. Infect. Immun. 1990, 58:3996.
170. Galleli A., Le Garrec Y., Chedid L. Increased resistance and depressed delayed-type hypersensitivity to Listeria monocytogenes induced by pretreatment with lipopolysaccharide. Infect. Immun. 1981, 31:88.
171. Bortolussi R., Rajaraman K., Serushago B. Role of tumor necrosis factor-alpha and interferon-gamma in newborn host defense against Listeria monocytogenes infection. Pediatr. Res. 1992, 32:460.
172. Brunda M.J. Interleukin-12. J. Leukoc. Biol. 1994, 55:280-288.
173. Serbina N.V., et al. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003, 19:891-901.
174. McKay D.B., Lu C.Y. Listeriolysin as a virulence factor in Listeria monocytogenes infection of neonatal mice and murine decidual tissue. Infect. Immun. 1991, 59:4286.
175. Bortolussi R. Neonatal listeriosis. Semin. Perinatol. 1990, 14:44.
176. Lu C.Y. The delayed ontogenesis of Ia-positive macrophages: implications for host defense and self-tolerance in the neonate. Clin. Invest. Med. 1984, 7:263.
177. Lu C.Y., Unanue E.R. Ontogeny of murine macrophages: functions related to antigen presentation. Infect. Immun. 1982, 36:169.
178. Lu C.Y., Calamai E.G., Unanue E.R. A defect in the antigen-presenting function of macrophages from neonatal mice. Nature 1979, 282:327.
179. Darmochwal-Kolarz D., et al. CD1c(+) immature myeloid dendritic cells are predominant in cord blood of healthy neonates. Immunol. Lett. 2004, 91:71-74.
180. Hamrick T.S., et al. Influence of pregnancy on the pathogenesis of listeriosis in mice inoculated intragastrically. Infect. Immun. 2003, 71:5202-5209.
181. Wilson C.B. The ontogeny of T lymphocyte maturation and function. J. Pediatr. 1991, 118:S4.
182. Bakardjiev A.I., et al. Listeriosis in the pregnant guinea pig: a model of vertical transmission. Infect. Immun. 2004, 72:489-497.
183. Le Monnier A., et al. ActA is required for crossing of the fetoplacental barrier by Listeria monocytogenes. Infect. Immun. 2007, 75:950-957.
184. Smith M.A., et al. Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infect. Immun. 2003, 71:1574-1579.
185. Issekutz T.B., Evans J., Bortolussi R. The immune response of human neonates to Listeria monocytogenes infection. Clin. Invest. Med. 1984, 7:281.
186. McDonald T., et al. Natural killer cell activity in very low birth weight infants. Pediatr. Res. 1992, 31:376.
187. Dominguez E., et al. Fetal natural killer cell function is suppressed. Immunology 1998, 94:109-114.
188. Lee S.M., et al. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996, 88:945-954.
189. Lau A.S., et al. Interleukin-12 induces interferon-gamma expression and natural killer cytotoxicity in cord blood mononuclear cells. Pediatr. Res. 1996, 39:150-155.
190. Bortolussi R., et al. Neonatal host defense mechanisms against Listeria monocytogenes infection: the role of lipopolysaccharides and interferons. Pediatr. Res. 1989, 25:311.
191. Murray H.W. Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense: in vitro, in animal models, and in humans. Diagn. Microbiol. Infect. Dis. 1990, 13:411.
192. Cederblad B., Riesenfeld T., Alm G.V. Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr. Res. 1990, 27:7.
193. Lewis D.B., Larsen A., Wilson C.B. Reduced interferon-gamma mRNA levels in human neonates: evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J. Exp. Med. 1986, 163:1018.
194. Lewis D.B., et al. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J. Clin. Invest. 1991, 87:194.
195. Bortolussi R., et al. Neonatal Listeria monocytogenes infection is refractory to interferon. Pediatr. Res. 1991, 29:400.
196. Al-Hertani W., et al. Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clin. Invest. Med. 2007, 30:E44-E53.
197. Bortolussi R. Escherichia coli infection in neonates: humoral defense mechanisms. Semin. Perinatol. 1990, 14:40.
198. Bortolussi R., Issekutz A., Faulkner G. Opsonization of Listeria monocytogenes type 4b by human adult and newborn sera. Infect. Immun. 1986, 52:493.
199. Hertzig T., et al. Antibodies present in normal human serum inhibit invasion of human brain microvascular endothelial cells by Listeria monocytogenes. Infect. Immun. 2003, 71:95-100.
200. Klatt E.C., et al. Epidemic perinatal listeriosis at autopsy. Hum. Pathol. 1986, 17:1278.
201. Scholing M., et al. Clinical features of liver involvement in adult patients with listeriosis: review of the literature. Infection 2007, 35:212-218.
202. Reiss H.J. Zur patholgischen Anatomie der kindlichen Listeriosis. Kinderarztl Prax Separatum 1953, 92.
203. Armstrong R.W., Fung P.C. Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin. Infect. Dis. 1993, 16:689-702.
204. Steele P.E., Jacobs D.S. Listeria monocytogenes: macroabscesses of placenta. Obstet. Gynecol. 1979, 53:124.
205. Topalovski M., Yang S.S., Boonpasat Y. Listeriosis of the placenta: clinicopathologic study of seven cases. Am. J. Obstet. Gynecol. 1993, 169:616-620.
206. Infections and inflammatory lesions of the placenta. Pathology of the Placenta 1997, 309-311. WB Saunders, Toronto. second ed. H. Fox (Ed.).
207. Presentation of case 15-1997 N. Engl. J. Med. 1997, 336:1439-1446.
208. Ahlfors C.E., et al. Neonatal listeriosis. Am. J. Dis. Child. 1977, 131:405.
209. Krause V.W., et al. Congenital listeriosis causing early neonatal death. Can. Med. Assoc. J. 1982, 127:36.
210. Hood M. Listeriosis as an infection of pregnancy manifested in the newborn. Pediatrics 1961, 27:390.
211. Kelly C.S., Gibson J.L. Listeriosis as a cause of fetal wastage. Obstet. Gynecol. 1972, 40:91.
212. Redline R.W., Lu C.Y. Specific defects in the anti-listerial immune response in discrete regions of the murine uterus and placenta account for susceptibility to infection. J. Immunol. 1988, 140:3947.
213. Kaur S., et al. Listeria monocytogenes in spontaneous abortions in humans and its detection by multiplex PCR. J. Appl. Microbiol. 2007, 103:1889-1896.
214. Kalstone C. Successful antepartum treatment of listeriosis. Am. J. Obstet. Gynecol. 1991, 164:57.
215. Liner R.I. Intrauterine Listeria infection: prenatal diagnosis by biophysical assessment and amniocentesis. Am. J. Obstet. Gynecol. 1990, 163:1596.
216. Loeb M.B., et al. Perinatal listeriosis. J. Soc. Obstet. Gynecol. Can. 1996, 18:164-170.
217. Luft B.J., Remington J.S. Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice. Infect. Immun. 1982, 38:1164.
218. Bortolussi R., Campbell N., Krause V. Dynamics of Listeria monocytogenes type 4b infection in pregnant and infant rats. Clin. Invest. Med. 1984, 7:273.
219. Lecuit M., et al. Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6152-6157.
220. Menu E., et al. Immunoactive products of human placenta. IV. Immunoregulatory factors obtained from cultures of human placenta inhibit in vivo local and systemic allogeneic and graft versus-host reactions in mice. J. Reprod. Immunol. 1991, 20:195.
221. Guleria I., Pollard J.W. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 2000, 6:589-593.
222. Burn C.G. Unidentified gram-positive bacillus associated with meningo-encephalitis. Proc. Soc. Exp. Biol. Med. 1934, 31:1095.
223. Burn C.G. Characteristics of a new species of the genus Listerella obtained from human sources. J. Bacteriol. 1935, 30:573.
224. Burn C.G. Clinical and pathological features of an infection caused by a new pathogen of the genus Listerella. Am. J. Pathol. 1936, 13:341.
225. Albritton W.L., Wiggins G.L., Feeley J.C. Neonatal listeriosis: distribution of serotypes in relation to age at onset of disease. J. Pediatr. 1976, 88:481.
226. Evans J.R., et al. Perinatal listeriosis: report of an outbreak. Pediatr. Infect. Dis. 1985, 4:237.
227. Lennon D., et al. Epidemic perinatal listeriosis. Pediatr. Infect. Dis. 1984, 3:30.
228. Becroft D.M., et al. Epidemic listeriosis in the newborn. BMJ 1971, 3:747.
229. McLauchlin J. Human listeriosis in Britain, 1967-85, a summary of 722 cases. 1. Listeriosis during pregnancy and in the newborn. Epidemiol. Infect. 1990, 104:181-189.
230. Visintine A.M., Oleske J.M., Nahmias A.J. Listeria monocytogenes infection in infants and children. Am. J. Dis. Child. 1977, 131:339.
231. Pron B., et al. Comprehensive study of the intestinal stage of listeriosis in a rat ligated ileal loop system. Infect. Immun. 1998, 66:747-755.
232. Dalton C.B., et al. An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N. Engl. J. Med. 1997, 336:100-105.
233. Brouwer M.C., et al. Community-acquired Listeria monocytogenes meningitis in adults. Clin. Infect. Dis. 2006, 43:1233-1238.
234. Antal E.A., et al. Brain stem encephalitis in listeriosis. Scand. J. Infect. Dis. 2005, 37:190-194.
235. Dramsi S., et al. Entry of Listeria monocytogenes into neurons occurs by cell-to-cell spread: an in vitro study. Infect. Immun. 1998, 66:4461-4468.
236. Sahin S., et al. Brain-stem listeriosis: a comparison of SPECT and MRI findings. Med. Gen. Med. 2006, 8:47.
237. Jurado R.L., et al. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 1993, 17:224-227.
238. Nadarajah K., Pritchard C. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis. J. Clin. Rheumatol. 2005, 11:120-122.
239. Anton W. Krittisch-experimenteller Beitrag zur Biologie des Bacterium-monocytogens mit besenderer Berucksichtigung seiner Bezehung zur infektiosen Mononukleose des Menschen. Zentralbl. Bakteriol. Hyg. 1934, 131:89.
240. Ooi S.T., Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin. Infect. Dis. 2005, 40:1327-1332.
241. Frye D.M., et al. An outbreak of febrile gastroenteritis associated with delicatessen meat contaminated with Listeria monocytogenes. Clin. Infect. Dis. 2002, 35:943-949.
242. Riedo F.X., et al. A point-source foodborne listeriosis outbreak: documented incubation period and possible mild illness. J. Infect. Dis. 1994, 170:693-696.
243. Salamina G., et al. A foodborne outbreak of gastroenteritis involving Listeria monocytogenes. Epidemiol. Infect. 1996, 117:429-436.
244. Aureli P., et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N. Engl. J. Med. 2000, 342:1236-1241.
245. Schlech W.F. Listeria gastroenteritis-old syndrome, new pathogen. N. Engl. J. Med. 1997, 336:130-132.
246. Felsenfeld O. Diseases of poultry transmissible to man. Iowa State Coll Vet 1951, 13:89.
247. Spyrou N., Anderson M., Foale R. Listeria endocarditis: current management and patient outcome-world literature review. Heart 1997, 77:380-383.
248. Miguel-Yanes J.M., Gonzalez-Ramallo V.J., Pastor L. Outcome of Listeria monocytogenes prosthetic valve endocarditis. As bad as it looks?. Scand. J. Infect. Dis. 2004, 36:709-711.
249. Jackson T.L., et al. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv. Ophthalmol. 2003, 48:403-423.
250. Betriu C., et al. Endophthalmitis caused by Listeria monocytogenes. J. Clin. Microbiol. 2001, 39:2742-2744.
251. Sivalingam J.J., et al. Listeria monocytogenes peritonitis: case report and literature review. Am. J. Gastroenterol. 1992, 87:1839-1845.
252. Dylewski J.S. Bacterial peritonitis caused by Listeria monocytogenes: case report and review of the literature. Can. J. Infect. 1996, 7:59-62.
253. Hof H. Therapeutic activities of antibiotics in listeriosis. Infection 1991, 19:S229.
254. McLauchlin J., Audurier A., Taylor A.G. Treatment failure and recurrent human listeriosis. J. Antimicrob. Chemother. 1991, 27:851.
255. Hudak A.P., et al. Comparison of three serological methods-enzyme-linked immunosorbent assay, complement fixation, and microagglutination-in the diagnosis of human perinatal Listeria monocytogenes infection. Clin. Invest. Med. 1984, 7:349.
256. Winblad S. Studies of antibodies in human listeriosis. Acta. Pathol. Microbiol. Scand. 1963, 58:123.
257. Berche P., et al. Detection of anti-listeriolysin O for serodiagnosis of human listeriosis. Lancet 1990, 335:624.
258. Drew R.M. Occurrence of two immunological groups within the genus Listeria: studies based upon precipitation reactions. Proc. Soc. Exp. Biol. Med. 1946, 61:30.
259. Schierz G., Burger A. The detection of Listeria antibodies by passive hemagglutination 1966, 77. Bilthoven.
260. Njoku-Obi A.N. An antigen-fixation test for the serodiagnosis of Listeria monocytogenes infections. Cornell. Vet. 1962, 52:415.
261. Kampelmacher E.H., Huysinga W.T., van Noorle Jansen L.M. Het voorkomen van Listeria monocytogenes in faeces van gravidae en pasgeborenen. Ned. Tijdschr. Geneeskd. 1972, 116:1685.
262. Backman A., et al. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol. Cell. Probes 1999, 13:49-60.
263. Lohmann C.P., et al. Listeria monocytogenes-induced endogenous endophthalmitis in an otherwise healthy individual: rapid PCR-diagnosis as the basis for effective treatment. Eur. J. Ophthalmol. 1999, 9:53-57.
264. Huijsdens X.W., et al. Listeria monocytogenes and inflammatory bowel disease: detection of Listeria species in intestinal mucosal biopsies by real-time PCR. Scand. J. Gastroenterol. 2003, 38:332-333.
265. Chiba M., et al. Presence of bacterial 16S ribosomal RNA gene segments in human intestinal lymph follicles. Scand. J. Gastroenterol. 2000, 35:824-831.
266. Hune O.S. Maternal Listeria monocytogenes septicemia with sparing of the fetus. Obstet. Gynecol. 1976, 48:335.
267. Katz V.L., Weinstein L. Antepartum treatment of Listeria monocytogenes septicemia. South. Med. J. 1982, 75:1353.
268. Fuchs S., Hochner-Celnikier D., Shalev O. First trimester listeriosis with normal fetal outcome. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13:656-658.
269. Rotheberg A.D., et al. Outcome for survivors of mechanical ventilation weighing less than 1200gm at birth. J. Pediatr. 1981, 98:106.
270. Naege R.L. Amnionic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment. Pediatrics 1978, 62:497.
271. Line F.G., Appleton F.G. Listeria meningitis in a premature infant. J. Pediatr. 1952, 41:97.
272. Evans J.R., et al. Follow-up study of survivors of fetal and early onset neonatal listeriosis. Clin. Invest. Med. 1984, 7:329.
273. Espaze E.P., et al. In vitro susceptibility of Listeria monocytogenes to some antibiotics and their combinations. Zentralbl. Bakteriol. [Orig. A] 1978, 240:76.
274. Watson G.W., et al. Listeria cerebritis: relapse of infection in renal transplant patients. Arch. Intern. Med. 1978, 138:83.
275. Hof H. Treatment of experimental listeriosis by CI 934, a new quinolone. J. Antimicrob. Chemother. 1990, 25:121.
276. Spitzer P.G., Hammer S.M., Karchmer A.W. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev. Infect. Dis. 1986, 8:427.
277. Armstrong R.W., Slater B. Listeria monocytogenes meningitis treated with trimethoprim-sulfamethoxazole. Pediatr. Infect. Dis. 1986, 5:712.
278. Vischer W.A., Rominger C. Rifampicin against experimental listeriosis in the mouse. Chemotherapy 1978, 24:104.
279. Poyart-Salmeron C., et al. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet 1990, 335:1422.
280. Clinical and Laboratory Standards Institute Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria: Approved Guideline. Approved Standard 2006, 26:27.
281. MacGowan A.P., et al. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur. J. Clin. Microbiol. Infect. Dis. 1990, 9:767.
282. Soriano F., Zapardiel J., Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob. Agents Chemother. 1995, 39:208-214.
283. Charpentier E., et al. Incidence of antibiotic resistance in Listeria species. J. Infect. Dis. 1995, 172:277-281.
284. Srinivasan V., et al. Prevalence of antimicrobial resistance genes in Listeria monocytogenes isolated from dairy farms. Foodborne Pathog. Dis. 2005, 2:201-211.
285. Prazak M.A., et al. Antimicrobial resistance of Listeria monocytogenes isolated from various cabbage farms and packing sheds in Texas. J. Food Prot. 2002, 65:1796-1799.
286. Hof H., Nichterlein T., Kretschmar M. Management of listeriosis. Clin. Microbiol. Rev. 1997, 10:345-357.
287. Traub W.H. Perinatal listeriosis: Tolerance of a clinical isolate of Listeria monocytogenes for ampicillin and resistance against cefotaxime. Chemotherapy 1981, 27:423.
288. Carryn S., et al. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob. Agents Chemother. 2002, 46:2095-2103.
289. Martinez-Martinez L., et al. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples. Antimicrob. Agents Chemother. 2001, 45:2390-2392.
290. Lavetter A., et al. Meningitis due to Listeria monocytogenes: a review of 25 cases. N. Engl. J. Med. 1971, 285:598.
291. Eliopoulos G.M., Moellering R.C. Susceptibility of enterococci and Listeria monocytogenes to N-formimidoyl thienamycin alone and in combination with an aminoglycoside. Antimicrob. Agents Chemother. 1981, 19:789.
292. Edmiston C.E., Gordon R.C. Evaluation of gentamicin and penicillin as a synergistic combination in experimental murine listeriosis. Antimicrob. Agents Chemother. 1979, 16:862.
293. van Ogtrop M.L., et al. Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice. Antimicrob. Agents Chemother. 1992, 36:2375.
294. Hof H., Emmerling P., Seeliger H.P. Murine model for therapy of listeriosis in the compromised host. Chemotherapy 1981, 27:214.
295. Bakker-Woudenberg I.A., et al. Efficacy of ampicillin therapy in experimental listeriosis in mice with impaired T-cell-mediated immune response. Antimicrob. Agents Chemother. 1981, 19:76.
296. Bakker-Woudenberg I.A., et al. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. J. Infect. Dis. 1985, 151:917.
297. Scheld W.M., et al. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J. Infect. Dis. 1979, 140:287.
298. Sipahi O.R., et al. Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis. J. Antimicrob. Chemother. 2008, 61:670-673.
299. Hawkins A.E., Bortolussi R., Issekutz A.C. In vitro and in vivo activity of various antibiotics against Listeria monocytogenes type 4b. Clin. Invest. Med. 1984, 7:335.
300. Dans P.E., et al. Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men. Am. J. Med. Sci. 1970, 259:120.
301. Hof H., Guckel H. Lack of synergism of ampicillin and gentamicin in experimental listeriosis. Infection 1987, 15:40.
302. Scheld W.M. Evaluation of rifampin and other antibiotics against Listeria monocytogenes in vitro and in vivo. Rev. Infect. Dis. 1983, 5:S593.
303. Cherubin C.E., et al. Epidemiological spectrum and current treatment of listeriosis. Rev. Infect. Dis. 1991, 13:1108.
304. Weingartner L., Ortel S. Zur Behandlung der Listeriose mit Ampicillin. Dtsch. Med. Wochenschr. 1967, 92:1098.
305. Safdar A., Armstrong D. Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997). J. Clin. Microbiol. 2003, 41:483-485.
306. Hansen J.M., Gerner-Smidt P., Bruun B. Antibiotic susceptibility of Listeria monocytogenes in Denmark 1958-2001. APMIS 2005, 113:31-36.
307. Forna F., et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev. 2006, 8:24-36.
308. Fanos V., Dall'Agnola A. Antibiotics in neonatal infections: a review. Drugs 1999, 58:405-427.
309. Petrilli E.S., D'Ablaing G., Ledger W.J. Listeria monocytogenes chorioamnionitis: diagnosis by transabdominal amniocentesis. Obstet. Gynecol. 1980, 55:5S.
310. CDC Update: foodborne listeriosis-United States, 1988-1990. MMWR Morbid. Mortal. Wkly Rep. 1992, 41:251.
311. Ogunmodede F., et al. Listeriosis prevention knowledge among pregnant women in the USA. Infect. Dis. Obstet. Gynecol. 2005, 13:11-15.
312. Bondarianzadeh D., Yeatman H., Condon-Paoloni D. Listeria education in pregnancy: lost opportunity for health professionals. Aust. N. Z. J. Public Health 2007, 31:468-474.
313. Tappero J.W., et al. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA 1995, 273:1118-1122.
314. Listeria Fact Sheet-Updated 2003, University of Guelph Food Safety Network, Guelph, Ontario.
315. Torres D., Barrier M., Bihl F., et al. Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection. Infection and Immunity 2004, 72:2131-2139.